Skip to main content
. 2022 Dec 21;15(1):24. doi: 10.3390/nu15010024

Figure 8.

Figure 8

Intestinal permeability evaluation two weeks after DCA vehicle (Non-IBS), 4 mmol/L DCA (IBS), L. fermentum (109 CFU) (L. ferm), Gabapentin at 70 mg/kg (GBP) or Rifaximin at 150 mg/kg (RFX) administration. (a) Muc-3 gene expression; (b) FITC-dextran assay and (c) occludin protein expression. Groups with different letters statistically differ (p < 0.05).